Literature DB >> 25326392

Glucocerebrosidase deficiency in zebrafish affects primary bone ossification through increased oxidative stress and reduced Wnt/β-catenin signaling.

Ilaria Zancan1, Stefania Bellesso2, Roberto Costa1, Marika Salvalaio2, Marina Stroppiano3, Chrissy Hammond4, Francesco Argenton5, Mirella Filocamo3, Enrico Moro6.   

Abstract

Loss of lysosomal glucocerebrosidase (GBA1) function is responsible for several organ defects, including skeletal abnormalities in type 1 Gaucher disease (GD). Enhanced bone resorption by infiltrating macrophages has been proposed to lead to major bone defects. However, while more recent evidences support the hypothesis that osteoblastic bone formation is impaired, a clear pathogenetic mechanism has not been depicted yet. Here, by combining different molecular approaches, we show that Gba1 loss of function in zebrafish is associated with defective canonical Wnt signaling, impaired osteoblast differentiation and reduced bone mineralization. We also provide evidence that increased reactive oxygen species production precedes the Wnt signaling impairment, which can be reversed upon human GBA1 overexpression. Type 1 GD patient fibroblasts similarly exhibit reduced Wnt signaling activity, as a consequence of increased β-catenin degradation. Our results support a novel model in which a primary defect in canonical Wnt signaling antecedes bone defects in type 1 GD.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25326392     DOI: 10.1093/hmg/ddu538

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  19 in total

Review 1.  GBA1 mutations: Prospects for exosomal biomarkers in α-synuclein pathologies.

Authors:  Parker H Johnson; Neal J Weinreb; James C Cloyd; Paul J Tuite; Reena V Kartha
Journal:  Mol Genet Metab       Date:  2019-10-23       Impact factor: 4.797

2.  Role of β-glucosidase 2 in aberrant glycosphingolipid metabolism: model of glucocerebrosidase deficiency in zebrafish.

Authors:  Lindsey T Lelieveld; Mina Mirzaian; Chi-Lin Kuo; Marta Artola; Maria J Ferraz; Remco E A Peter; Hisako Akiyama; Peter Greimel; Richard J B H N van den Berg; Herman S Overkleeft; Rolf G Boot; Annemarie H Meijer; Johannes M F G Aerts
Journal:  J Lipid Res       Date:  2019-09-27       Impact factor: 5.922

3.  Glucocerebrosidases catalyze a transgalactosylation reaction that yields a newly-identified brain sterol metabolite, galactosylated cholesterol.

Authors:  Hisako Akiyama; Mitsuko Ide; Yasuko Nagatsuka; Tomoko Sayano; Etsuro Nakanishi; Norihito Uemura; Kohei Yuyama; Yoshiki Yamaguchi; Hiroyuki Kamiguchi; Ryosuke Takahashi; Johannes M F G Aerts; Peter Greimel; Yoshio Hirabayashi
Journal:  J Biol Chem       Date:  2020-03-06       Impact factor: 5.157

Review 4.  From Channels to Canonical Wnt Signaling: A Pathological Perspective.

Authors:  Silvia Muccioli; Valentina Brillo; Leonardo Chieregato; Luigi Leanza; Vanessa Checchetto; Roberto Costa
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

5.  Glucocerebrosidase 1 deficient Danio rerio mirror key pathological aspects of human Gaucher disease and provide evidence of early microglial activation preceding alpha-synuclein-independent neuronal cell death.

Authors:  Marcus Keatinge; Hai Bui; Aswin Menke; Yu-Chia Chen; Anna M Sokol; Qing Bai; Felix Ellett; Marc Da Costa; Derek Burke; Matthew Gegg; Lisa Trollope; Thomas Payne; Aimee McTighe; Heather Mortiboys; Sarah de Jager; Hugh Nuthall; Ming-Shang Kuo; Angeleen Fleming; Anthony H V Schapira; Stephen A Renshaw; J Robin Highley; Agnieszka Chacinska; Pertti Panula; Edward A Burton; Michael J O'Neill; Oliver Bandmann
Journal:  Hum Mol Genet       Date:  2015-09-16       Impact factor: 6.150

6.  Osteocyte Alterations Induce Osteoclastogenesis in an In Vitro Model of Gaucher Disease.

Authors:  Constanza Bondar; Maximiliano Ormazabal; Andrea Crivaro; Malena Ferreyra-Compagnucci; María Victoria Delpino; Paula Adriana Rozenfeld; Juan Marcos Mucci
Journal:  Int J Mol Sci       Date:  2017-01-13       Impact factor: 5.923

7.  Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of β-catenin signaling.

Authors:  Daniel C Berwick; Behzad Javaheri; Andrea Wetzel; Mark Hopkinson; Jonathon Nixon-Abell; Simone Grannò; Andrew A Pitsillides; Kirsten Harvey
Journal:  Mol Neurodegener       Date:  2017-01-19       Impact factor: 14.195

Review 8.  Fish Models of Induced Osteoporosis.

Authors:  Joana T Rosa; Vincent Laizé; Paulo J Gavaia; M Leonor Cancela
Journal:  Front Cell Dev Biol       Date:  2021-06-10

9.  Tcf7l2 plays pleiotropic roles in the control of glucose homeostasis, pancreas morphology, vascularization and regeneration.

Authors:  Nicola Facchinello; Estefania Tarifeño-Saldivia; Enrico Grisan; Marco Schiavone; Margherita Peron; Alessandro Mongera; Olivier Ek; Nicole Schmitner; Dirk Meyer; Bernard Peers; Natascia Tiso; Francesco Argenton
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

10.  Brain RNA-Seq Profiling of the Mucopolysaccharidosis Type II Mouse Model.

Authors:  Marika Salvalaio; Francesca D'Avanzo; Laura Rigon; Alessandra Zanetti; Michela D'Angelo; Giorgio Valle; Maurizio Scarpa; Rosella Tomanin
Journal:  Int J Mol Sci       Date:  2017-05-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.